-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
The company has been awarded the “AAA Credit Rating Enterprise in the Pharmaceutical Industry.”
Category:
Time：2019-12-20
On December 20, the China Association of Chemical Pharmaceutical Industry, leading a coalition of eight national industry associations—including the China Association of Traditional Chinese Medicine—and 14 provincial and municipal pharmaceutical industry associations—including the Hebei Province Pharmaceutical Industry Association—successfully held in Beijing the First Joint Meeting of Industry Associations on the Construction of a Credit System in the Medical and Pharmaceutical Sectors. Shi Jianhui, Party Secretary of the company, was invited to attend the meeting.
On December 20, the China Association of Pharmaceutical Manufacturers, leading a coalition of eight national industry associations—including the China Association of Traditional Chinese Medicine—and 14 provincial and municipal pharmaceutical industry associations—including the Hebei Province Pharmaceutical Industry Association—successfully held in Beijing the First Joint Meeting of Industry Associations on the Construction of a Credit System in the Medical and Pharmaceutical Sectors. Shi Jianhui, Party Secretary of the company, was invited to attend the meeting.
This conference is themed “Promoting Industry Self-Discipline and Upholding a Culture of Integrity,” with the primary mission of guiding member enterprises to “Comply with Laws, Uphold Creditworthiness, and Value Contracts.” Its overarching goal is to “Enhance the industry’s credit management capabilities and build a business environment characterized by honesty and trustworthiness,” thereby serving enterprises, the industry, the government, and society at large and fostering high-quality development of the pharmaceutical industry.
At the meeting, the results of the 2019 pharmaceutical industry enterprise credit ratings were announced, and our company was awarded the “Pharmaceutical Industry AAA Credit Rating.” It is understood that this evaluation was conducted from an objective and impartial third-party perspective, using a standardized assessment indicator system, scientific evaluation methods, and rigorous evaluation procedures. The process involved collecting and analyzing credit information from enterprises participating in the 2019 pharmaceutical industry credit rating, conducting on-site inspections within these enterprises, and gaining a comprehensive understanding of their credit-related operations. Based on the rating results provided by the third-party credit service agency and after thoroughly soliciting opinions from industry experts, the final results were determined.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license